Pred Phos-Gati-Brom is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Imprimis Njof, Llc. The primary component is Prednisolone Sodium Phosphate; Gatifloxacin; Bromfenac.
| Product ID | 71384-550_6e130dfe-e946-bc9f-e053-2991aa0a55b7 |
| NDC | 71384-550 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pred Phos-Gati-Brom |
| Generic Name | Prednisolone Phosphate - Gatifloxacin - Bromfenac |
| Dosage Form | Solution/ Drops |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2018-07-02 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Imprimis NJOF, LLC |
| Substance Name | PREDNISOLONE SODIUM PHOSPHATE; GATIFLOXACIN; BROMFENAC |
| Active Ingredient Strength | 10 mg/mL; mg/mL; mg/mL |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Quinolone Antimicrobial [EPC],Quinolones [CS],Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2018-07-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2018-07-02 |
| Marketing End Date | 2019-07-01 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-02-12 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2018-07-02 |
| Marketing End Date | 2019-07-01 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-02-12 |
| Ingredient | Strength |
|---|---|
| PREDNISOLONE SODIUM PHOSPHATE | 10 mg/mL |
| SPL SET ID: | 6dd75810-da95-28aa-e053-2a91aa0a0dab |
| Manufacturer | |
| UNII | |
| PHarm Class EPC | |
| NUI Code |